Most Recent
Cor Cordis sued by ex-chair who claims firm undervalued WIP
The former chair of Cor Cordis has sued the insolvency firm, claiming it passed resolutions in “bad faith” that reduced the value of its work in progress from $23 million to $12.7 million to avoid paying out his proper retirement entitlements. 
CIMIC to face non-use cross-claim in suit over Leyton trade mark
CIMIC faces a cross-claim in its trade mark infringement case against developer Leyton Property, which wants the building giant's Leighton marks removed from the registry for non-use.
Victoria can’t dodge full costs in pepper spray class action, flags appeal
Victoria may appeal a decision in a class action that found police unlawfully deployed pepper spray at a 2019 protest, a court has heard, as the state loses a bid to avoid the applicant's full legal costs.
Coles urges court not to second guess its ‘commercial’ judgment
Facing claims it misled customers with its 'Down Down' pricing, Coles has urged the court not to second guess its judgment, but a judge overseeing the case has said competitive pressures do not excuse misleading promotions.
AFR resolves defamation suit by Bird’s Basement owner
Nine's Australian Financial Review has resolved a defamation suit by the owner of Melbourne jazz venue Bird's Basement over articles about a former employee's now discontinued suit.
Court tosses greenwashing case against Santos over net zero claims
A court has tossed a landmark greenwashing case against Santos alleging it misled investors by falsely representing that it had a plausible path to net zero by 2040.
Twitter defeats case over replies to alleged defamatory tweets
A judge has ruled that a self-represented litigant who settled proceedings against Twitter in 2021 over alleged defamatory tweets cannot pursue a case over replies later made to those tweets.
AstraZeneca wins injunction against Pharmacor’s generic diabetes drug
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
Ashurst nabs insolvency lawyer from HWL Ebsworth
Ashurst has appointed a new partner to its restructuring and governance practice, nabbing a partner from HWL Ebsworth who represented the receivers of investment platform Brite Advisors.
Keystone’s Paul Chiodo can’t dodge receivers’ subpoenas for bank records
Ex-Keystone director Paul Chiodo has failed in his fight against subpoenas by receivers over bank statements, despite arguing they were a fishing expedition aimed at clawing back investor funds.